nodes	percent_of_prediction	percent_of_DWPC	metapath
Varenicline—CHRNB2—saliva-secreting gland—thyroid cancer	0.0164	0.117	CbGeAlD
Varenicline—CHRNA6—head—thyroid cancer	0.0154	0.111	CbGeAlD
Varenicline—CHRNA7—neck—thyroid cancer	0.0133	0.0952	CbGeAlD
Varenicline—CHRNB2—trachea—thyroid cancer	0.0126	0.0905	CbGeAlD
Varenicline—CHRNB2—thyroid gland—thyroid cancer	0.00999	0.0716	CbGeAlD
Varenicline—CHRFAM7A—trachea—thyroid cancer	0.00991	0.071	CbGeAlD
Varenicline—CHRNB2—head—thyroid cancer	0.00886	0.0635	CbGeAlD
Varenicline—CHRNA3—head—thyroid cancer	0.0086	0.0616	CbGeAlD
Varenicline—CHRFAM7A—thyroid gland—thyroid cancer	0.00784	0.0561	CbGeAlD
Varenicline—CHRFAM7A—head—thyroid cancer	0.00695	0.0498	CbGeAlD
Varenicline—CHRNA7—thyroid gland—thyroid cancer	0.00633	0.0453	CbGeAlD
Varenicline—CHRNB2—lymph node—thyroid cancer	0.00621	0.0445	CbGeAlD
Varenicline—CHRNA3—lymph node—thyroid cancer	0.00602	0.0431	CbGeAlD
Varenicline—CHRNA7—head—thyroid cancer	0.00562	0.0402	CbGeAlD
Varenicline—CHRNA4—head—thyroid cancer	0.00554	0.0397	CbGeAlD
Varenicline—Constipation—Sorafenib—thyroid cancer	0.00129	0.0015	CcSEcCtD
Varenicline—Pain—Sorafenib—thyroid cancer	0.00129	0.0015	CcSEcCtD
Varenicline—Hypertonia—Doxorubicin—thyroid cancer	0.00127	0.00147	CcSEcCtD
Varenicline—Eczema—Epirubicin—thyroid cancer	0.00126	0.00147	CcSEcCtD
Varenicline—Eye pain—Epirubicin—thyroid cancer	0.00126	0.00146	CcSEcCtD
Varenicline—Mental disability—Doxorubicin—thyroid cancer	0.00126	0.00146	CcSEcCtD
Varenicline—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00123	0.00143	CcSEcCtD
Varenicline—Lymphadenopathy—Doxorubicin—thyroid cancer	0.00123	0.00143	CcSEcCtD
Varenicline—Renal failure acute—Epirubicin—thyroid cancer	0.00123	0.00143	CcSEcCtD
Varenicline—Hot flush—Epirubicin—thyroid cancer	0.00121	0.00141	CcSEcCtD
Varenicline—Increased appetite—Epirubicin—thyroid cancer	0.00121	0.0014	CcSEcCtD
Varenicline—Diabetes mellitus—Doxorubicin—thyroid cancer	0.00121	0.0014	CcSEcCtD
Varenicline—Menopausal symptoms—Epirubicin—thyroid cancer	0.0012	0.0014	CcSEcCtD
Varenicline—Urticaria—Sorafenib—thyroid cancer	0.0012	0.00139	CcSEcCtD
Varenicline—Body temperature increased—Sorafenib—thyroid cancer	0.00119	0.00139	CcSEcCtD
Varenicline—Abdominal pain—Sorafenib—thyroid cancer	0.00119	0.00139	CcSEcCtD
Varenicline—Eczema—Doxorubicin—thyroid cancer	0.00117	0.00136	CcSEcCtD
Varenicline—Eye pain—Doxorubicin—thyroid cancer	0.00116	0.00135	CcSEcCtD
Varenicline—Hypoglycaemia—Epirubicin—thyroid cancer	0.00116	0.00135	CcSEcCtD
Varenicline—Lethargy—Epirubicin—thyroid cancer	0.00116	0.00135	CcSEcCtD
Varenicline—Cerebrovascular accident—Epirubicin—thyroid cancer	0.00116	0.00135	CcSEcCtD
Varenicline—Renal failure acute—Doxorubicin—thyroid cancer	0.00114	0.00132	CcSEcCtD
Varenicline—Osteoarthritis—Epirubicin—thyroid cancer	0.00113	0.00132	CcSEcCtD
Varenicline—Gastrointestinal haemorrhage—Epirubicin—thyroid cancer	0.00113	0.00132	CcSEcCtD
Varenicline—Hot flush—Doxorubicin—thyroid cancer	0.00112	0.0013	CcSEcCtD
Varenicline—Increased appetite—Doxorubicin—thyroid cancer	0.00112	0.0013	CcSEcCtD
Varenicline—Affect lability—Epirubicin—thyroid cancer	0.00112	0.0013	CcSEcCtD
Varenicline—Migraine—Epirubicin—thyroid cancer	0.00112	0.0013	CcSEcCtD
Varenicline—Menopausal symptoms—Doxorubicin—thyroid cancer	0.00111	0.00129	CcSEcCtD
Varenicline—Hypersensitivity—Sorafenib—thyroid cancer	0.00111	0.00129	CcSEcCtD
Varenicline—Asthenia—Sorafenib—thyroid cancer	0.00108	0.00126	CcSEcCtD
Varenicline—Hypoglycaemia—Doxorubicin—thyroid cancer	0.00108	0.00125	CcSEcCtD
Varenicline—Mood swings—Epirubicin—thyroid cancer	0.00108	0.00125	CcSEcCtD
Varenicline—Lethargy—Doxorubicin—thyroid cancer	0.00107	0.00125	CcSEcCtD
Varenicline—Cerebrovascular accident—Doxorubicin—thyroid cancer	0.00107	0.00125	CcSEcCtD
Varenicline—Pruritus—Sorafenib—thyroid cancer	0.00107	0.00124	CcSEcCtD
Varenicline—Osteoarthritis—Doxorubicin—thyroid cancer	0.00105	0.00122	CcSEcCtD
Varenicline—Gastrointestinal haemorrhage—Doxorubicin—thyroid cancer	0.00105	0.00122	CcSEcCtD
Varenicline—Liver function test abnormal—Epirubicin—thyroid cancer	0.00105	0.00122	CcSEcCtD
Varenicline—Dry skin—Epirubicin—thyroid cancer	0.00104	0.00121	CcSEcCtD
Varenicline—Abdominal pain upper—Epirubicin—thyroid cancer	0.00104	0.0012	CcSEcCtD
Varenicline—Migraine—Doxorubicin—thyroid cancer	0.00103	0.0012	CcSEcCtD
Varenicline—Affect lability—Doxorubicin—thyroid cancer	0.00103	0.0012	CcSEcCtD
Varenicline—Hypokalaemia—Epirubicin—thyroid cancer	0.00103	0.0012	CcSEcCtD
Varenicline—Diarrhoea—Sorafenib—thyroid cancer	0.00103	0.0012	CcSEcCtD
Varenicline—Breast disorder—Epirubicin—thyroid cancer	0.00103	0.00119	CcSEcCtD
Varenicline—Nasopharyngitis—Epirubicin—thyroid cancer	0.00101	0.00118	CcSEcCtD
Varenicline—Gastritis—Epirubicin—thyroid cancer	0.001	0.00117	CcSEcCtD
Varenicline—Dizziness—Sorafenib—thyroid cancer	0.000998	0.00116	CcSEcCtD
Varenicline—Mood swings—Doxorubicin—thyroid cancer	0.000995	0.00116	CcSEcCtD
Varenicline—Abdominal distension—Epirubicin—thyroid cancer	0.000987	0.00115	CcSEcCtD
Varenicline—Dysphagia—Epirubicin—thyroid cancer	0.000981	0.00114	CcSEcCtD
Varenicline—Asthma—Epirubicin—thyroid cancer	0.000981	0.00114	CcSEcCtD
Varenicline—Liver function test abnormal—Doxorubicin—thyroid cancer	0.000969	0.00113	CcSEcCtD
Varenicline—Dry skin—Doxorubicin—thyroid cancer	0.000962	0.00112	CcSEcCtD
Varenicline—Vomiting—Sorafenib—thyroid cancer	0.00096	0.00112	CcSEcCtD
Varenicline—Abdominal pain upper—Doxorubicin—thyroid cancer	0.000959	0.00111	CcSEcCtD
Varenicline—Hypokalaemia—Doxorubicin—thyroid cancer	0.000956	0.00111	CcSEcCtD
Varenicline—Angina pectoris—Epirubicin—thyroid cancer	0.000955	0.00111	CcSEcCtD
Varenicline—Rash—Sorafenib—thyroid cancer	0.000952	0.00111	CcSEcCtD
Varenicline—Dermatitis—Sorafenib—thyroid cancer	0.000951	0.00111	CcSEcCtD
Varenicline—Breast disorder—Doxorubicin—thyroid cancer	0.000949	0.0011	CcSEcCtD
Varenicline—Headache—Sorafenib—thyroid cancer	0.000946	0.0011	CcSEcCtD
Varenicline—Bronchitis—Epirubicin—thyroid cancer	0.000943	0.0011	CcSEcCtD
Varenicline—Nasopharyngitis—Doxorubicin—thyroid cancer	0.000939	0.00109	CcSEcCtD
Varenicline—Gastritis—Doxorubicin—thyroid cancer	0.000929	0.00108	CcSEcCtD
Varenicline—Abdominal distension—Doxorubicin—thyroid cancer	0.000914	0.00106	CcSEcCtD
Varenicline—Dysphagia—Doxorubicin—thyroid cancer	0.000908	0.00105	CcSEcCtD
Varenicline—Asthma—Doxorubicin—thyroid cancer	0.000908	0.00105	CcSEcCtD
Varenicline—Pollakiuria—Epirubicin—thyroid cancer	0.000906	0.00105	CcSEcCtD
Varenicline—Nausea—Sorafenib—thyroid cancer	0.000896	0.00104	CcSEcCtD
Varenicline—Photosensitivity reaction—Epirubicin—thyroid cancer	0.000895	0.00104	CcSEcCtD
Varenicline—Weight increased—Epirubicin—thyroid cancer	0.000893	0.00104	CcSEcCtD
Varenicline—Hyperglycaemia—Epirubicin—thyroid cancer	0.000885	0.00103	CcSEcCtD
Varenicline—Angina pectoris—Doxorubicin—thyroid cancer	0.000884	0.00103	CcSEcCtD
Varenicline—Infestation NOS—Epirubicin—thyroid cancer	0.000875	0.00102	CcSEcCtD
Varenicline—Infestation—Epirubicin—thyroid cancer	0.000875	0.00102	CcSEcCtD
Varenicline—Bronchitis—Doxorubicin—thyroid cancer	0.000873	0.00101	CcSEcCtD
Varenicline—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000867	0.00101	CcSEcCtD
Varenicline—Stomatitis—Epirubicin—thyroid cancer	0.000852	0.000991	CcSEcCtD
Varenicline—Conjunctivitis—Epirubicin—thyroid cancer	0.00085	0.000988	CcSEcCtD
Varenicline—Pollakiuria—Doxorubicin—thyroid cancer	0.000838	0.000974	CcSEcCtD
Varenicline—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000828	0.000963	CcSEcCtD
Varenicline—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000827	0.000961	CcSEcCtD
Varenicline—Weight increased—Doxorubicin—thyroid cancer	0.000826	0.00096	CcSEcCtD
Varenicline—Epistaxis—Epirubicin—thyroid cancer	0.000825	0.000959	CcSEcCtD
Varenicline—Sinusitis—Epirubicin—thyroid cancer	0.00082	0.000954	CcSEcCtD
Varenicline—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000819	0.000952	CcSEcCtD
Varenicline—Infestation—Doxorubicin—thyroid cancer	0.000809	0.000941	CcSEcCtD
Varenicline—Infestation NOS—Doxorubicin—thyroid cancer	0.000809	0.000941	CcSEcCtD
Varenicline—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000802	0.000932	CcSEcCtD
Varenicline—Bradycardia—Epirubicin—thyroid cancer	0.000799	0.000929	CcSEcCtD
Varenicline—Stomatitis—Doxorubicin—thyroid cancer	0.000789	0.000917	CcSEcCtD
Varenicline—Conjunctivitis—Doxorubicin—thyroid cancer	0.000787	0.000914	CcSEcCtD
Varenicline—Hypoaesthesia—Epirubicin—thyroid cancer	0.000781	0.000908	CcSEcCtD
Varenicline—Urinary tract disorder—Epirubicin—thyroid cancer	0.000775	0.000901	CcSEcCtD
Varenicline—Oedema peripheral—Epirubicin—thyroid cancer	0.000773	0.000899	CcSEcCtD
Varenicline—Connective tissue disorder—Epirubicin—thyroid cancer	0.000772	0.000897	CcSEcCtD
Varenicline—Urethral disorder—Epirubicin—thyroid cancer	0.00077	0.000894	CcSEcCtD
Varenicline—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000765	0.00089	CcSEcCtD
Varenicline—Epistaxis—Doxorubicin—thyroid cancer	0.000763	0.000887	CcSEcCtD
Varenicline—Sinusitis—Doxorubicin—thyroid cancer	0.000759	0.000882	CcSEcCtD
Varenicline—Visual impairment—Epirubicin—thyroid cancer	0.000757	0.000879	CcSEcCtD
Varenicline—Erythema multiforme—Epirubicin—thyroid cancer	0.000742	0.000863	CcSEcCtD
Varenicline—Bradycardia—Doxorubicin—thyroid cancer	0.00074	0.00086	CcSEcCtD
Varenicline—Eye disorder—Epirubicin—thyroid cancer	0.000734	0.000853	CcSEcCtD
Varenicline—Tinnitus—Epirubicin—thyroid cancer	0.000732	0.000851	CcSEcCtD
Varenicline—Cardiac disorder—Epirubicin—thyroid cancer	0.000729	0.000847	CcSEcCtD
Varenicline—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000723	0.00084	CcSEcCtD
Varenicline—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000717	0.000834	CcSEcCtD
Varenicline—Oedema peripheral—Doxorubicin—thyroid cancer	0.000716	0.000832	CcSEcCtD
Varenicline—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000714	0.00083	CcSEcCtD
Varenicline—Angiopathy—Epirubicin—thyroid cancer	0.000712	0.000828	CcSEcCtD
Varenicline—Urethral disorder—Doxorubicin—thyroid cancer	0.000712	0.000828	CcSEcCtD
Varenicline—Immune system disorder—Epirubicin—thyroid cancer	0.000709	0.000824	CcSEcCtD
Varenicline—Mediastinal disorder—Epirubicin—thyroid cancer	0.000708	0.000822	CcSEcCtD
Varenicline—Chills—Epirubicin—thyroid cancer	0.000704	0.000819	CcSEcCtD
Varenicline—Arrhythmia—Epirubicin—thyroid cancer	0.000701	0.000815	CcSEcCtD
Varenicline—Visual impairment—Doxorubicin—thyroid cancer	0.0007	0.000814	CcSEcCtD
Varenicline—Mental disorder—Epirubicin—thyroid cancer	0.000688	0.000799	CcSEcCtD
Varenicline—Erythema multiforme—Doxorubicin—thyroid cancer	0.000687	0.000798	CcSEcCtD
Varenicline—Malnutrition—Epirubicin—thyroid cancer	0.000683	0.000794	CcSEcCtD
Varenicline—Erythema—Epirubicin—thyroid cancer	0.000683	0.000794	CcSEcCtD
Varenicline—Eye disorder—Doxorubicin—thyroid cancer	0.000679	0.000789	CcSEcCtD
Varenicline—Tinnitus—Doxorubicin—thyroid cancer	0.000677	0.000787	CcSEcCtD
Varenicline—Cardiac disorder—Doxorubicin—thyroid cancer	0.000674	0.000784	CcSEcCtD
Varenicline—Flatulence—Epirubicin—thyroid cancer	0.000673	0.000783	CcSEcCtD
Varenicline—Dysgeusia—Epirubicin—thyroid cancer	0.000669	0.000778	CcSEcCtD
Varenicline—Back pain—Epirubicin—thyroid cancer	0.000661	0.000768	CcSEcCtD
Varenicline—Angiopathy—Doxorubicin—thyroid cancer	0.000659	0.000766	CcSEcCtD
Varenicline—Muscle spasms—Epirubicin—thyroid cancer	0.000657	0.000764	CcSEcCtD
Varenicline—Immune system disorder—Doxorubicin—thyroid cancer	0.000656	0.000763	CcSEcCtD
Varenicline—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000655	0.000761	CcSEcCtD
Varenicline—Chills—Doxorubicin—thyroid cancer	0.000652	0.000758	CcSEcCtD
Varenicline—Arrhythmia—Doxorubicin—thyroid cancer	0.000649	0.000754	CcSEcCtD
Varenicline—Vision blurred—Epirubicin—thyroid cancer	0.000644	0.000749	CcSEcCtD
Varenicline—Mental disorder—Doxorubicin—thyroid cancer	0.000636	0.00074	CcSEcCtD
Varenicline—Ill-defined disorder—Epirubicin—thyroid cancer	0.000634	0.000737	CcSEcCtD
Varenicline—Erythema—Doxorubicin—thyroid cancer	0.000632	0.000735	CcSEcCtD
Varenicline—Malnutrition—Doxorubicin—thyroid cancer	0.000632	0.000735	CcSEcCtD
Varenicline—Anaemia—Epirubicin—thyroid cancer	0.000632	0.000734	CcSEcCtD
Varenicline—Agitation—Epirubicin—thyroid cancer	0.000628	0.00073	CcSEcCtD
Varenicline—Flatulence—Doxorubicin—thyroid cancer	0.000623	0.000724	CcSEcCtD
Varenicline—Dysgeusia—Doxorubicin—thyroid cancer	0.000619	0.00072	CcSEcCtD
Varenicline—Malaise—Epirubicin—thyroid cancer	0.000616	0.000716	CcSEcCtD
Varenicline—Vertigo—Epirubicin—thyroid cancer	0.000614	0.000714	CcSEcCtD
Varenicline—Syncope—Epirubicin—thyroid cancer	0.000613	0.000712	CcSEcCtD
Varenicline—Back pain—Doxorubicin—thyroid cancer	0.000612	0.000711	CcSEcCtD
Varenicline—Muscle spasms—Doxorubicin—thyroid cancer	0.000608	0.000707	CcSEcCtD
Varenicline—Palpitations—Epirubicin—thyroid cancer	0.000604	0.000702	CcSEcCtD
Varenicline—Loss of consciousness—Epirubicin—thyroid cancer	0.000601	0.000698	CcSEcCtD
Varenicline—Cough—Epirubicin—thyroid cancer	0.000596	0.000693	CcSEcCtD
Varenicline—Vision blurred—Doxorubicin—thyroid cancer	0.000596	0.000693	CcSEcCtD
Varenicline—Convulsion—Epirubicin—thyroid cancer	0.000592	0.000688	CcSEcCtD
Varenicline—Hypertension—Epirubicin—thyroid cancer	0.00059	0.000686	CcSEcCtD
Varenicline—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000587	0.000682	CcSEcCtD
Varenicline—Anaemia—Doxorubicin—thyroid cancer	0.000584	0.000679	CcSEcCtD
Varenicline—Myalgia—Epirubicin—thyroid cancer	0.000582	0.000676	CcSEcCtD
Varenicline—Arthralgia—Epirubicin—thyroid cancer	0.000582	0.000676	CcSEcCtD
Varenicline—Chest pain—Epirubicin—thyroid cancer	0.000582	0.000676	CcSEcCtD
Varenicline—Agitation—Doxorubicin—thyroid cancer	0.000581	0.000675	CcSEcCtD
Varenicline—Anxiety—Epirubicin—thyroid cancer	0.00058	0.000674	CcSEcCtD
Varenicline—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000578	0.000672	CcSEcCtD
Varenicline—Discomfort—Epirubicin—thyroid cancer	0.000575	0.000668	CcSEcCtD
Varenicline—Malaise—Doxorubicin—thyroid cancer	0.00057	0.000663	CcSEcCtD
Varenicline—Dry mouth—Epirubicin—thyroid cancer	0.000569	0.000661	CcSEcCtD
Varenicline—Vertigo—Doxorubicin—thyroid cancer	0.000568	0.00066	CcSEcCtD
Varenicline—Syncope—Doxorubicin—thyroid cancer	0.000567	0.000659	CcSEcCtD
Varenicline—Palpitations—Doxorubicin—thyroid cancer	0.000559	0.00065	CcSEcCtD
Varenicline—Oedema—Epirubicin—thyroid cancer	0.000558	0.000648	CcSEcCtD
Varenicline—Loss of consciousness—Doxorubicin—thyroid cancer	0.000556	0.000646	CcSEcCtD
Varenicline—Infection—Epirubicin—thyroid cancer	0.000554	0.000644	CcSEcCtD
Varenicline—Cough—Doxorubicin—thyroid cancer	0.000552	0.000641	CcSEcCtD
Varenicline—Shock—Epirubicin—thyroid cancer	0.000549	0.000638	CcSEcCtD
Varenicline—Convulsion—Doxorubicin—thyroid cancer	0.000548	0.000637	CcSEcCtD
Varenicline—Nervous system disorder—Epirubicin—thyroid cancer	0.000547	0.000636	CcSEcCtD
Varenicline—Thrombocytopenia—Epirubicin—thyroid cancer	0.000546	0.000635	CcSEcCtD
Varenicline—Hypertension—Doxorubicin—thyroid cancer	0.000546	0.000635	CcSEcCtD
Varenicline—Tachycardia—Epirubicin—thyroid cancer	0.000544	0.000633	CcSEcCtD
Varenicline—Skin disorder—Epirubicin—thyroid cancer	0.000542	0.00063	CcSEcCtD
Varenicline—Hyperhidrosis—Epirubicin—thyroid cancer	0.000539	0.000627	CcSEcCtD
Varenicline—Chest pain—Doxorubicin—thyroid cancer	0.000538	0.000626	CcSEcCtD
Varenicline—Arthralgia—Doxorubicin—thyroid cancer	0.000538	0.000626	CcSEcCtD
Varenicline—Myalgia—Doxorubicin—thyroid cancer	0.000538	0.000626	CcSEcCtD
Varenicline—Anxiety—Doxorubicin—thyroid cancer	0.000537	0.000624	CcSEcCtD
Varenicline—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000535	0.000621	CcSEcCtD
Varenicline—Discomfort—Doxorubicin—thyroid cancer	0.000532	0.000618	CcSEcCtD
Varenicline—Anorexia—Epirubicin—thyroid cancer	0.000532	0.000618	CcSEcCtD
Varenicline—Dry mouth—Doxorubicin—thyroid cancer	0.000527	0.000612	CcSEcCtD
Varenicline—Hypotension—Epirubicin—thyroid cancer	0.000521	0.000606	CcSEcCtD
Varenicline—Oedema—Doxorubicin—thyroid cancer	0.000516	0.0006	CcSEcCtD
Varenicline—Infection—Doxorubicin—thyroid cancer	0.000513	0.000596	CcSEcCtD
Varenicline—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000508	0.000591	CcSEcCtD
Varenicline—Shock—Doxorubicin—thyroid cancer	0.000508	0.00059	CcSEcCtD
Varenicline—Nervous system disorder—Doxorubicin—thyroid cancer	0.000506	0.000588	CcSEcCtD
Varenicline—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000505	0.000587	CcSEcCtD
Varenicline—Insomnia—Epirubicin—thyroid cancer	0.000504	0.000586	CcSEcCtD
Varenicline—Tachycardia—Doxorubicin—thyroid cancer	0.000504	0.000585	CcSEcCtD
Varenicline—Skin disorder—Doxorubicin—thyroid cancer	0.000501	0.000583	CcSEcCtD
Varenicline—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000499	0.00058	CcSEcCtD
Varenicline—Dyspnoea—Epirubicin—thyroid cancer	0.000497	0.000578	CcSEcCtD
Varenicline—Somnolence—Epirubicin—thyroid cancer	0.000496	0.000576	CcSEcCtD
Varenicline—Anorexia—Doxorubicin—thyroid cancer	0.000492	0.000572	CcSEcCtD
Varenicline—Dyspepsia—Epirubicin—thyroid cancer	0.000491	0.000571	CcSEcCtD
Varenicline—Decreased appetite—Epirubicin—thyroid cancer	0.000485	0.000564	CcSEcCtD
Varenicline—Hypotension—Doxorubicin—thyroid cancer	0.000482	0.000561	CcSEcCtD
Varenicline—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000482	0.00056	CcSEcCtD
Varenicline—Fatigue—Epirubicin—thyroid cancer	0.000481	0.000559	CcSEcCtD
Varenicline—Pain—Epirubicin—thyroid cancer	0.000477	0.000554	CcSEcCtD
Varenicline—Constipation—Epirubicin—thyroid cancer	0.000477	0.000554	CcSEcCtD
Varenicline—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.00047	0.000547	CcSEcCtD
Varenicline—Insomnia—Doxorubicin—thyroid cancer	0.000467	0.000543	CcSEcCtD
Varenicline—Dyspnoea—Doxorubicin—thyroid cancer	0.00046	0.000535	CcSEcCtD
Varenicline—Feeling abnormal—Epirubicin—thyroid cancer	0.00046	0.000534	CcSEcCtD
Varenicline—Somnolence—Doxorubicin—thyroid cancer	0.000459	0.000533	CcSEcCtD
Varenicline—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000456	0.00053	CcSEcCtD
Varenicline—Dyspepsia—Doxorubicin—thyroid cancer	0.000454	0.000528	CcSEcCtD
Varenicline—Decreased appetite—Doxorubicin—thyroid cancer	0.000449	0.000521	CcSEcCtD
Varenicline—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000446	0.000518	CcSEcCtD
Varenicline—Fatigue—Doxorubicin—thyroid cancer	0.000445	0.000517	CcSEcCtD
Varenicline—Urticaria—Epirubicin—thyroid cancer	0.000443	0.000515	CcSEcCtD
Varenicline—Constipation—Doxorubicin—thyroid cancer	0.000441	0.000513	CcSEcCtD
Varenicline—Pain—Doxorubicin—thyroid cancer	0.000441	0.000513	CcSEcCtD
Varenicline—Abdominal pain—Epirubicin—thyroid cancer	0.000441	0.000512	CcSEcCtD
Varenicline—Body temperature increased—Epirubicin—thyroid cancer	0.000441	0.000512	CcSEcCtD
Varenicline—Feeling abnormal—Doxorubicin—thyroid cancer	0.000425	0.000494	CcSEcCtD
Varenicline—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000422	0.000491	CcSEcCtD
Varenicline—Hypersensitivity—Epirubicin—thyroid cancer	0.000411	0.000478	CcSEcCtD
Varenicline—Urticaria—Doxorubicin—thyroid cancer	0.00041	0.000477	CcSEcCtD
Varenicline—Abdominal pain—Doxorubicin—thyroid cancer	0.000408	0.000474	CcSEcCtD
Varenicline—Body temperature increased—Doxorubicin—thyroid cancer	0.000408	0.000474	CcSEcCtD
Varenicline—Asthenia—Epirubicin—thyroid cancer	0.0004	0.000465	CcSEcCtD
Varenicline—Pruritus—Epirubicin—thyroid cancer	0.000395	0.000459	CcSEcCtD
Varenicline—Diarrhoea—Epirubicin—thyroid cancer	0.000382	0.000444	CcSEcCtD
Varenicline—Hypersensitivity—Doxorubicin—thyroid cancer	0.00038	0.000442	CcSEcCtD
Varenicline—Asthenia—Doxorubicin—thyroid cancer	0.00037	0.00043	CcSEcCtD
Varenicline—Dizziness—Epirubicin—thyroid cancer	0.000369	0.000429	CcSEcCtD
Varenicline—Pruritus—Doxorubicin—thyroid cancer	0.000365	0.000424	CcSEcCtD
Varenicline—Vomiting—Epirubicin—thyroid cancer	0.000355	0.000412	CcSEcCtD
Varenicline—Diarrhoea—Doxorubicin—thyroid cancer	0.000353	0.00041	CcSEcCtD
Varenicline—Rash—Epirubicin—thyroid cancer	0.000352	0.000409	CcSEcCtD
Varenicline—Dermatitis—Epirubicin—thyroid cancer	0.000351	0.000408	CcSEcCtD
Varenicline—Headache—Epirubicin—thyroid cancer	0.000349	0.000406	CcSEcCtD
Varenicline—Dizziness—Doxorubicin—thyroid cancer	0.000341	0.000397	CcSEcCtD
Varenicline—Nausea—Epirubicin—thyroid cancer	0.000331	0.000385	CcSEcCtD
Varenicline—Vomiting—Doxorubicin—thyroid cancer	0.000328	0.000381	CcSEcCtD
Varenicline—Rash—Doxorubicin—thyroid cancer	0.000325	0.000378	CcSEcCtD
Varenicline—Dermatitis—Doxorubicin—thyroid cancer	0.000325	0.000378	CcSEcCtD
Varenicline—Headache—Doxorubicin—thyroid cancer	0.000323	0.000376	CcSEcCtD
Varenicline—Nausea—Doxorubicin—thyroid cancer	0.000307	0.000356	CcSEcCtD
